Pasar al contenido principal

EFECTOS DE LA VITAMINA D SOBRE LAS CELULAS TRONCALES Y EL MICROAMBIENTE TUMORAL EN CANCER DE COLON: DIFERENCIACION, METABOLISMO Y COMUNICACION INTERCELULAR

PREP2022-000611

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprograma Subprograma Estatal de Formación
Convocatoria Contratos Predoctorales
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Calcitriol modulates age-dependent drug response in paired patient-derived normal and tumor colorectal organoids

  • Fernández-Barral, Asunción
  • Barbáchano, Antonio
  • Rodríguez-Marrero, Silvia
  • Peso, Luis del
  • Herreros-Cabello, Alfonso
  • Arroyo-Gascón, Estrella
  • Rodríguez-Salas, Nuria
  • Prieto, Isabel
  • Burgos, Aurora
  • León-Arellano, Miguel
  • García-Olmo, Damián
  • Olleros, Tomás
  • González-Sancho, José Manuel
  • Larriba, María Jesús
  • Muñoz, Alberto
The incidence of early-onset colorectal cancer (EO-CRC, <50 years) is rising worldwide, highlighting the need to better understand the underlying causes of this age-related divergence. We used paired patient-derived normal and tumor colorectal organoids to investigate the therapeutic window of chemotherapeutic agents and its modulation by calcitriol (the most active vitamin D metabolite). Dose-response analyses revealed marked interpatient variability, with SN38 being more potent than 5-fluorouracil (5-FU) and oxaliplatin. Normal organoids were more resistant than paired tumor counterparts to 5-FU and oxaliplatin in both EO-CRC and late-onset CRC (LO-CRC, >50 years), indicating selective tumor cytotoxicity. In contrast, the therapeutic window for SN38 was preserved in LO-CRC but not in EO-CRC organoids, revealing age-dependent differences in drug sensitivity. Moreover, calcitriol reduced the cytotoxicity of 5-FU and SN38 in normal organoids regardless of patient age, while in tumor organoids this protective effect was restricted to EO-CRC. As a consequence, calcitriol treatment selectively expanded the therapeutic window for 5-FU and SN38 in LO-CRC organoids. Mechanistically, these effects correlated with calcitriol-induced antiproliferative action and transcriptional regulation of drug metabolism-related pathways. Overall, our findings identify age-dependent differences in chemotherapy response and support the importance of maintaining adequate vitamin D status to reduce chemotherapy-associated toxicity., This study has been funded by Instituto de Salud Carlos III (ISCIII) through the project ICI20/00057 and co-funded by the European Union. Additional support was provided by grants CIBERONC/CB16/12/00273, CIBERONC/CB16/12/00398, and CIBERES/CB15/00037 funded by the Instituto de Salud Carlos III (ISCIII) - FEDER, UE. This work was also supported by grant PID2019-104867RB-I00 funded by MICIU/AEI/10.13039/501100011033; grant PID2022-136729OB-I00 funded by MICIU/AEI/10.13039/501100011033 and FEDER, UE and grant S2022/BMD-7212 funded by Comunidad de Madrid. SR-M was supported by grant PREP2022-000611 funded by MICIU/AEI/10.13039/501100011033 and FSE+. EA-G was supported by grant FPU24/03135 funded by Ministerio de Ciencia, Innovación y Universidades. AF-B, AB, SR-M, AH-C, EA-G, JMG-S, MJL and AM belong to the Spanish National Research Council (CSIC)'s Cancer Hub., Peer reviewed